i'm thinking the same. and i think things will st

i'm thinking the same. and i think things will start coming out of the woodwork pretty darn soon.
1) aggregated safety data submitted, just waiting for acceptance from FDA.
2) with FDA acceptance, hold shall be lifted
3) BLA for HIV can then proceed and who wouldn't want to partner on that?, especially since trial was successful and aggregated safety was good; now BLA just needs writing and we will partner to do that.
4) NASH is probably better than we think and Dr. Noureddin will tell it like it is. Some one wants in on NASH.
5) mTNBC, it has been over 6 months since the BTD application. We were to continued dosing. and we should still be dosing. We have MD Anderson working with PD 1 and PD 2 / PD L1 and PD L2 inhibitors and may find they too are beneficial in mTNBC as they found out in that colon cancer with dolstarimab spelling?? 100% effectivity. I think a company with PD1 inhibitor will want to combine with LL to go for BTD for mTNBC using our new data for PFS and OS which would blow away current PFS and OS.

any one of these things happen, we approach $9 again